A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|5|1455-1458

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.5, 2015-05, pp. : 1455-1458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 2, 2018-02 ,pp. : 258-265

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections

By  

HEPATOLOGY, Vol. 61, Iss. 2, 2015-02 ,pp. : 712-721

John Wiley & Sons Inc

Access to resources Recommend Favorite

Validation of hepatitis B virus–related hepatocellular carcinoma prediction models in the era of antiviral therapy

By  

HEPATOLOGY, Vol. 62, Iss. 6, 2015-12 ,pp. : 1757-1766

John Wiley & Sons Inc

Access to resources Recommend Favorite

Will IL28B polymorphism remain relevant in the era of direct‐acting antiviral agents for hepatitis C virus?

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 373-381

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Pathogenesis, Complications and Therapeutic Strategy for Hepatitis C Virus-associated Insulin Resistance in the Era of Anti-viral Treatment

By  

Reviews on Recent Clinical Trials, Vol. 5, Iss. 3, 2010-09 ,pp. : 147-157

Bentham Science Publishers

Access to resources Recommend Favorite